search
FTSE 100
Trends
- 1AstraZeneca invests $2bn in cancer drug partnership with Summit Therapeutics●📈 Astrazeneca invests $2bn in cancer drug tie-up Astrazeneca has invested $2bn in US pharmaceutical firm Summit Therapeu
AstraZeneca has invested $2bn in US biotech firm Summit Therapeutics as part of a major cancer research collaboration. The FTSE 100 drugmaker agreed to buy 109,000 shares in the Nasdaq-listed company at $18.36 per share, funding a tie-up aimed at developing new cancer treatments.
- 2FTSE 100 edges up on hopes of Iran diplomacy▼FTSE 100 today: Stocks edge up as Iran diplomacy hopes persist
The FTSE 100 rose modestly as investors grew more hopeful that diplomatic efforts over Iran could ease tensions. Reports carried by financial outlets in Australia, Singapore and beyond noted stocks inching higher, with markets cautiously pricing in the prospect of talks rather than escalation. Traders are watching for further signs of de-escalation in the region.